Opportunity Information: Apply for PA 18 280

The National Institutes of Health (NIH) funding opportunity "Targeted Implementation Science to Achieve 90/90/90 Goals for HIV/AIDS Prevention and Treatment (R21 Clinical Trial Optional)" (Funding Opportunity Number: PA-18-280) is a discretionary grant program intended to support short, focused implementation research projects that can help communities make measurable progress toward the global 90/90/90 HIV goals. The core idea is not simply to test whether an HIV intervention works in theory, but to study how to make proven HIV prevention and treatment strategies actually work better in real-world settings by addressing on-the-ground barriers in specific communities and service delivery systems. Projects are expected to be designed in partnership with domestic and international service providers so the research is practical, locally relevant, and directly connected to how care and prevention are delivered.

The FOA is explicitly anchored to the 90/90/90 targets widely adopted by HIV/AIDS leadership: first, that 90 percent of all people living with HIV know their HIV status (improving testing, diagnosis, and linkage from testing to care); second, that 90 percent of those diagnosed begin timely and effective antiretroviral therapy (ART) (improving treatment initiation, retention in care, and reducing delays or drop-off); and third, that 90 percent of those on ART achieve sustained viral suppression (improving adherence support, clinical monitoring, service delivery quality, and long-term engagement). The announcement emphasizes "targeted" implementation science, meaning applicants should focus on the particular needs of the chosen community or service setting, rather than proposing generic improvements. In practice, this typically points to projects that identify bottlenecks along the HIV care continuum and test strategies for adoption, integration, scale-up, or sustainment of evidence-based approaches in clinics, community programs, public health systems, or hybrid service models.

The mechanism is an NIH R21, which is commonly used for exploratory or developmental research. This suggests the program is looking for well-justified, innovative, and feasible pilot or early-phase implementation studies that can produce actionable lessons and position teams for larger-scale follow-on work. The FOA is labeled "Clinical Trial Optional," meaning applicants may propose a clinical trial if it fits the implementation research question, but a clinical trial is not required. The award ceiling listed is $200,000, reinforcing that these are meant to be smaller, targeted projects rather than large, multi-year programmatic efforts.

Eligibility is broad and includes many types of U.S. and non-U.S. organizations. Eligible applicants include state, county, city or township, and special district governments; independent school districts; public and state-controlled and private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized governments; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses) as well as small businesses; and other organizations. The FOA also calls out additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based and community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-domestic (non-U.S.) entities/foreign organizations. This wide eligibility aligns with the FOA's emphasis on partnering with real-world service providers and reaching populations that may be underserved or disproportionately impacted by HIV.

From a topic standpoint, the funding activity is categorized under education and health, and it is associated with CFDA numbers 93.242 and 93.361. The opportunity was created on 2017-11-29, and the original closing date listed is 2020-01-07. Overall, the FOA is best understood as an NIH effort to accelerate progress toward the 90/90/90 benchmarks by funding practical implementation research that is embedded in service settings, tailored to local needs, and capable of improving outcomes across HIV testing, treatment initiation, and sustained viral suppression.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Targeted Implementation Science to Achieve 90/90/90 Goals for HIV/AIDS Prevention and Treatment (R21 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242, 93.361.
  • This funding opportunity was created on 2017-11-29.
  • Applicants must submit their applications by 2020-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $200,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PA 18 280

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is the name of this NIH funding opportunity?

The funding opportunity is titled "Targeted Implementation Science to Achieve 90/90/90 Goals for HIV/AIDS Prevention and Treatment (R21 Clinical Trial Optional)."

What is the Funding Opportunity Number (FON)?

The Funding Opportunity Number is PA-18-280.

What type of grant mechanism is used?

This opportunity uses the NIH R21 mechanism, which is commonly intended for exploratory or developmental research projects.

What is the overall purpose of this grant?

The purpose is to support short, focused implementation research projects that help communities make measurable progress toward the global 90/90/90 HIV goals by improving how proven HIV prevention and treatment strategies work in real-world settings.

What does "implementation science" mean in this announcement?

In this announcement, implementation science focuses on studying how to make evidence-based HIV prevention and treatment strategies work better in practice by addressing on-the-ground barriers in specific communities and service delivery systems, rather than only testing whether an intervention works in theory.

What does "targeted" implementation science mean here?

"Targeted" means projects should be tailored to the specific needs of the chosen community or service setting, rather than proposing generic improvements. This often involves identifying bottlenecks along the HIV care continuum and testing strategies to improve adoption, integration, scale-up, or sustainment in real service environments.

What are the 90/90/90 goals referenced in the FOA?

The FOA is anchored to three widely adopted HIV targets: (1) 90 percent of people living with HIV know their HIV status, (2) 90 percent of those diagnosed begin timely and effective antiretroviral therapy (ART), and (3) 90 percent of those on ART achieve sustained viral suppression.

Which parts of the HIV continuum of care does this FOA emphasize?

The FOA emphasizes improvements across HIV testing and diagnosis, linkage from testing to care, treatment initiation, retention in care, adherence support, clinical monitoring, service delivery quality, and long-term engagement needed to achieve sustained viral suppression.

Are projects expected to partner with service providers?

Yes. Projects are expected to be designed in partnership with domestic and international service providers so the research is practical, locally relevant, and directly connected to how prevention and care are delivered.

Does this opportunity require a clinical trial?

No. The FOA is labeled "Clinical Trial Optional," meaning a clinical trial may be proposed if it fits the implementation research question, but a clinical trial is not required.

What is the award ceiling for this opportunity?

The listed award ceiling is $200,000, signaling that projects are intended to be smaller and targeted rather than large, multi-year programmatic efforts.

What kinds of projects are a good fit for an NIH R21 in this FOA?

The FOA points to well-justified, innovative, and feasible pilot or early-phase implementation studies that can produce actionable lessons and position teams for larger-scale follow-on work.

Who is eligible to apply?

Eligibility is broad and includes many U.S. and non-U.S. organizations, including various government entities, institutions of higher education, tribal governments and organizations, public housing authorities/Indian housing authorities, nonprofits (with or without 501(c)(3) status), for-profit organizations (other than small businesses), small businesses, and other organizations.

Are non-U.S. (foreign) organizations eligible?

Yes. The FOA explicitly includes non-domestic (non-U.S.) entities/foreign organizations among eligible applicants.

Are U.S. territories or possessions included as eligible applicants?

Yes. The FOA lists U.S. territories or possessions among additional eligible applicants.

Are tribal entities eligible to apply?

Yes. Eligibility includes federally recognized Native American tribal governments and tribal organizations other than federally recognized governments, as well as Tribally Controlled Colleges and Universities (TCCUs).

Are community-based and faith-based organizations eligible?

Yes. The FOA calls out faith-based and community-based organizations as additional eligible applicants.

Are minority-serving institutions explicitly included?

Yes. The FOA highlights eligibility for institutions such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), and Tribally Controlled Colleges and Universities (TCCUs).

What kinds of service settings are mentioned as potential sites for implementation research?

The FOA references implementation in clinics, community programs, public health systems, and hybrid service models, with an emphasis on real-world service delivery systems.

What is the main difference between this FOA and a traditional efficacy study?

This FOA is not primarily about proving an HIV intervention works under ideal conditions. Instead, it focuses on how to improve the real-world delivery, adoption, integration, scale-up, or sustainment of proven strategies by addressing barriers in specific communities and systems.

What is the funding activity category listed for this opportunity?

The funding activity is categorized under education and health.

What CFDA numbers are associated with this opportunity?

The opportunity is associated with CFDA numbers 93.242 and 93.361.

When was this opportunity created?

The opportunity was created on 2017-11-29.

What is the original closing date listed for this FOA?

The original closing date listed is 2020-01-07.

What does success look like for projects funded under this FOA?

Based on the FOA description, success is tied to generating practical, locally relevant implementation lessons that help improve measurable progress toward the 90/90/90 benchmarks across testing/diagnosis, ART initiation/retention, and sustained viral suppression.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Organic Transitions

Previous opportunity: Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 18 280

 

Applicants also applied for:

Applicants who have applied for this opportunity (PA 18 280) also looked into and applied for these:

Funding Opportunity
Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01 Clinical Trial Optional) Apply for PAR 18 249

Funding Number: PAR 18 249
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Health Services Research on Minority Health and Health Disparities (R01 Clinical Trial Optional) Apply for PAR 18 286

Funding Number: PAR 18 286
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Health Services Research on Minority Health and Health Disparities (R21 Clinical Trial Optional) Apply for PAR 18 287

Funding Number: PAR 18 287
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
NIDA Program Project Grant Applications (P01, Clinical Trial Optional) Apply for PAR 18 425

Funding Number: PAR 18 425
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Building Evidence: Effective Palliative/End of Life Care Interventions (R01 Clinical Trial Optional) Apply for PAR 18 173

Funding Number: PAR 18 173
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Image-guided Drug Delivery (R01 Clinical Trial Optional) Apply for PAR 18 252

Funding Number: PAR 18 252
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Exploratory/Developmental Surgical Disparities Research (R21 Clinical Trial Optional) Apply for PAR 18 289

Funding Number: PAR 18 289
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) Apply for PAR 18 224

Funding Number: PAR 18 224
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional) Apply for PAR 18 225

Funding Number: PAR 18 225
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) Apply for PAR 18 292

Funding Number: PAR 18 292
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Multi-Site Pilot and Feasibility Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional) Apply for PAR 18 223

Funding Number: PAR 18 223
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $225,000
Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R21 Clinical Trial Optional) Apply for PAR 18 250

Funding Number: PAR 18 250
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R01 Clinical Trial Optional) Apply for PAR 18 251

Funding Number: PAR 18 251
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional) Apply for PAR 18 222

Funding Number: PAR 18 222
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) Apply for PAR 18 226

Funding Number: PAR 18 226
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Obesity and Asthma: Awareness and Self- Management (R01 Clinical Trial Optional) Apply for PA 18 379

Funding Number: PA 18 379
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Cancer Research Education Grants Program - Curriculum or Methods Development (R25) Apply for PAR 18 476

Funding Number: PAR 18 476
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Cancer Research Education Grants Program - Research Experiences (R25) Apply for PAR 18 478

Funding Number: PAR 18 478
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Cancer Research Education Grants Program - Courses for Skills Development (R25) Apply for PAR 18 477

Funding Number: PAR 18 477
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1, Clinical Trial Optional) Apply for RFA DA 18 019

Funding Number: RFA DA 18 019
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 18 280", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: